PORTON Biopharma Limited (PBL) has opened a £1.3 million extension to its pharmaceutical stores.
PBL manufactures a number of bio-pharmaceutical products and the company was commercialised out of Public Health England earlier this year to enable it to have more operational freedom, which includes the ability to invest in key facilities.
Martin Hindle, chairman of PBL, said: “This new extension is the first physical demonstration of the belief that we all have in the company and our vision for the future. By building up our capacity it will enable us to grow the business, thereby securing the future for our staff and providing more life-saving products.”
The extension adds an additional space for goods receipt/booking-in and quarantine storage to the existing building.
In addition to the extension there is also an improved access ramp, as well additional external corrosive and flammable stores.
PBL was formed in April and employs more than 200 people. It is co-located with Public Health England on the Porton Down Science Campus.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here